论著·临床研究

去甲肾上腺素预防剖宫产腰硬联合麻醉后低血压的90%有效剂量的临床研究

  • SHEN Ting ,
  • XU Tao ,
  • ZHENG Jing ,
  • AN Xiao-hu ,
  • XU Zi-feng ,
  • CHAI Jing
展开
  • 上海交通大学医学院附属国际和平妇幼保健院麻醉科,上海市胚胎源性疾病重点实验室, 上海 200030
沈 婷(1986—),女,主治医师,硕士;电子信箱:stanna_100@163.com。

网络出版日期: 2021-01-13

基金资助

上海市临床重点专科(建设项目)-“强主体”妇产科项目;上海申康医院发展中心临床科技创新项目(SHDC12016225)。

A clinical research of ED90 norepinephrine to prevent hypotension after combined spinal and epidural anesthesia during cesarean delivery

  • 沈 婷,徐 韬,郑 静,安小虎,徐子锋,柴 静
Expand
  • Department of Anesthesiology, the International Peace Maternity & Child Health Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Key Laboratory of Embryo Original Diseases, Shanghai 200030, China

Online published: 2021-01-13

Supported by

Project of Shanghai Municipal Key Clinical Specialty-Gynecological and Obstetrical Item; Clinical Science and Technology Innovation Program from Shanghai Hospital Development Center (SHDC12016225).

摘要

目的·通过序贯分析法确定择期剖宫产蛛网膜下腔联合硬膜外麻醉(腰硬联合麻醉)后90%产妇不发生低血压的去甲肾上腺素静脉推注剂量。方法·根据偏倚钱币序贯法依次对40例择期剖宫产的产妇进行前瞻性双盲序贯研究。主要观察指标为胎儿娩出前维持产妇收缩压高于其基础值80%所使用的去甲肾上腺素静脉推注剂量。次要观察指标包括头晕、胸闷、恶心、呕吐、心动过缓、继发性高血压、补救性使用阿托品的发生率、补救性使用去甲肾上腺素的发生率,以及新生儿1 min和5 min Apgar评分等。使用Isotonic回归分析估计90%有效剂量(90% effective dose,ED90)及其95%CI。结果·腰硬联合麻醉后预防性静脉推注去甲肾上腺素维持产妇血压的ED90为[10.85(95%CI 9.20~11.67)] μg。产妇头晕、胸闷、恶心的发生率分别为2.5%、7.5%和10.0%,补救性使用去甲肾上腺素发生率为5.0%;未出现呕吐、心动过缓、继发性高血压及补救性使用阿托品。所有新生儿1 min及5 min Apgar评分均为10分。结论·建议剖宫产腰硬联合麻醉后单次静脉推注去甲肾上腺素11 μg,以预防产妇麻醉后低血压的发生。

本文引用格式

SHEN Ting , XU Tao , ZHENG Jing , AN Xiao-hu , XU Zi-feng , CHAI Jing . 去甲肾上腺素预防剖宫产腰硬联合麻醉后低血压的90%有效剂量的临床研究[J]. 上海交通大学学报(医学版), 2020 , 40(11) : 1495 -1499 . DOI: 10.3969/j.issn.1674-8115.2020.11.010

Abstract

Objective · To determine the optimal intravenous norepinephrine bolus dose needed to prevent hypotension after combined spinal and epidural anesthesia in 90% of women during elective cesarean delivery. Methods · Forty women undergoing elective cesarean delivery were allocated into this double-blinded, prospective, and sequential dose-finding study using biased coin design sequential method. The primary outcome was the successful use of the norepinephrine bolus dose to maintain systolic blood pressure above 80% of the baseline until delivery. Secondary outcomes included dizziness, breathlessness, nausea, vomiting, bradycardia, secondary hypertension and supplemental use of atropine or norepinephrine of the women, as well as 1 min and 5 min Apgar scores of the newborns. The 90% effective dose (ED90) and its 95%CI were estimated using Isotonic regression methods. Results · The estimated ED90 intravenous bolus dose of norepinephrine was [10.85 (95%CI 9.20-11.67)] μg to prevent hypotension after combined spinal and epidural anesthesia during cesarean delivery. The occurrence rates of dizziness, breathlessness, and nausea were 2.5%, 7.5% and 10.0%, respectively. The occurrence rate of additional rescue norepinephrine boluses was 5.0%. No vomiting, bradycardia, secondary hypertension and supplemental use of atropine appeared. Apgar scores of all newborns at 1 min and 5 min were 10. Conclusion · An intravenous norepinephrine bolus dose of 11 μg is recommended to prevent hypotension after combined spinal and epidural anesthesia during cesarean delivery for clinical practice.
文章导航

/